August 31, 2022
Viatris Pharmaceuticals Japan said on August 30 that it has started the patient enrollment of a Japanese PIII trial for its antidepressant Effexor SR (venlafaxine) for the treatment of generalized anxiety disorder (GAD). In Japan, Pfizer obtained approval for Effexor...read more